Related Experiment Video
Updated: Jul 17, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Percutaneous valve interventions
1Department of Cardiac Surgery, New York-Cornell Medical Center, New York, USA. ars9001@med.cornell.edu
Insights
Percutaneous valve therapies offer a less invasive alternative to open heart surgery for valvular heart disease. These closed-chest procedures show promise for high-risk patients, though long-term durability requires further study.
Area of Science:
- Cardiovascular medicine
- Interventional cardiology
- Biomedical engineering
Background:
- Open heart surgery for valvular heart disease, while effective, involves cardiopulmonary bypass, prolonged recovery, and surgical risks.
- Percutaneous valve interventions represent a minimally invasive, closed-chest alternative.
- These novel approaches are particularly beneficial for patients deemed high-risk or inoperable for traditional surgery.
Purpose of the Study:
- To review the emerging field of percutaneous valve interventions as an alternative to conventional open heart surgery.
- To highlight the potential benefits and current status of these closed-chest procedures for valvular heart disease.
Main Methods:
- Evaluation of various percutaneous devices currently under clinical investigation for aortic and mitral valve positions.
- Review of early clinical outcomes and ongoing research in percutaneous valve replacement and repair.
Main Results:
- Several percutaneous devices are being evaluated for different heart valves, with a focus on aortic and mitral positions.
- Initial clinical results are promising, indicating feasibility and potential efficacy.
- Longer-term follow-up data are essential to establish the durability and long-term safety of these interventions.
Conclusions:
- Percutaneous valve therapies are an emerging field offering valve interventions without cardiopulmonary bypass.
- These techniques expand treatment options for patients with valvular heart disease, especially those at high surgical risk.
- Continued development of devices and extended follow-up studies are crucial for advancing this innovative treatment modality.
Purpose Of Review:
Open heart surgery has long been considered the gold standard for treatment of patients with valvular heart disease. Although results are excellent, this technique requires the use of cardiopulmonary bypass and is associated with protracted recovery and attendant risks of open surgery. The field of percutaneous valve interventions has emerged as a closed-chest alternative for all patients, but particularly those who otherwise would be considered too high risk for open surgery.
Recent Findings:
Several devices are currently being evaluated in the clinical realm for each heart valve, particularly for the aortic and mitral positions. Early results are promising, but longer follow-up is necessary to determine durability of the procedures.
Summary:
Although only in its infancy, percutaneous valve therapies offer heart valve interventions without the use of cardiopulmonary bypass. This creates many new possibilities for patients, especially those who are deemed either high risk or inoperable by the usual surgical standards. Newer device iterations and longer term follow-up will be necessary as the field moves forward.
Related Concept Videos
Mitral Stenosis III: Medical Management
Endocarditis IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization IV: Nursing Management